BackgroundPatients with schizophrenia are known to have poor oral health and to die early from cardiovascular disease. It is also known that Porphyromonas gingivalis is a periodontopathogen, which is implicated in a number of systemic diseases, particularly cardiovascular disease. However, little, if any, is known about the prevalence and the quantity of this organism in the mouth of patients with schizophrenia. Aim To estimate the prevalence and quantity of P. gingivalis in saliva of patients with schizophrenia compared with nonpsychiatric controls and to correlate the quantity of P. gingivalis with the severity of psychopathology of schizophrenia. Methods Forty-three consecutive Arab attendees of the outpatient clinic of a psychiatric Hospital in Jeddah, with a diagnosis of schizophrenia, were assessed by the Positive and Negative Syndrome Scale and the Clinical Global Impression-Severity Scale. They were compared with 43 nonpsychiatric controls, in terms of the prevalence and in terms of the quantity of P. gingivalis in their saliva. For this purpose, anerobic culture and real-time polymerase chain reaction (PCR) with a TaqMan probe were used. Results In 82 (approximately 95%) participants, the real-time PCR results were matching those obtained with anerobic culture. Using real-time PCR, P. gingivalis was detected in 30 (approximately 70%) patients and in six (approximately 14%) controls (P = 0.000). The P. gingivalis median (range) number of copies in salivary samples of patients and controls were 5.6 Â 10 7 (0-2. 79 10 ) and 1.9 Â 10 5 (0-6.84 7 ), respectively (P = 0.002). In addition, the P. gingivalis levels were positively correlated with the scores on all the Positive and Negative Syndrome Scale and Clinical Global Impression-Severity Scale. Conclusion Real-time PCR, in keeping with the results of quantitative culture, showed that (i) there is a higher prevalence and quantity of P. gingivalis in saliva of a sample of Arab patients with schizophrenia compared with nonpsychiatric controls and (ii) that there is a positive correlation between quantity of P. gingivalis cells and the severity of psychopathology of schizophrenia. Hopefully, the results of this pilot study will encourage further research into the relationships between oral microbiota and schizophrenia. Real-time PCR, as demonstrated by this study, is a promising tool in this area. It is also hoped that some preventive dental programs will become an integral part of a comprehensive psychiatric management to meet the need of this vulnerable group of population.